These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16493381)

  • 21. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K; Finer N; Rössner S
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
    Kiortsis DN; Tsouli S; Filippatos TD; Konitsiotis S; Elisaf MS
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M; Aronne LJ
    Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orlistat and sibutramine beyond weight loss.
    Mannucci E; Dicembrini I; Rotella F; Rotella CM
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C
    Diabetes Educ; 2006; 32(6):910-7. PubMed ID: 17102158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.
    Navarro-Díaz M; Serra A; Romero R; Bonet J; Bayés B; Homs M; Pérez N; Bonal J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S213-7. PubMed ID: 17130264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin and body weight.
    Golay A
    Int J Obes (Lond); 2008 Jan; 32(1):61-72. PubMed ID: 17653063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
    Andersson C; Weeke P; Fosbøl EL; Brendorp B; Køber L; Coutinho W; Sharma AM; Van Gaal L; Finer N; James WP; Caterson ID; Rode RA; Torp-Pedersen C; ;
    Metabolism; 2009 Aug; 58(8):1109-15. PubMed ID: 19454355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bariatric surgery in paediatrics--when and how?
    Fried M
    Int J Pediatr Obes; 2008 Oct; 3 Suppl 2():15-9; discussion 20. PubMed ID: 18850407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
    Early JL; Apovian CM; Aronne LJ; Fernstrom MH; Frank A; Greenway FL; Heber D; Kushner RF; Cwik KM; Walch JK; Hewkin AC; Blakesley V
    Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effect of ileogastrostomy surgery for morbid obesity on diabetes mellitus and sleep apnea.
    Cleator IG; Birmingham CL; Kovacevic S; Cleator MM; Gritzner S
    Obes Surg; 2006 Oct; 16(10):1337-41. PubMed ID: 17059744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity: weight loss without drugs: a balanced diet avoiding high-calorie foods, plus exercise.
    Prescrire Int; 2007 Aug; 16(90):162-7. PubMed ID: 17724845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary treatment for obesity.
    Clifton PM
    Nat Clin Pract Gastroenterol Hepatol; 2008 Dec; 5(12):672-81. PubMed ID: 18852729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sibutramine-associated adverse effects: a practical guide for its safe use.
    Florentin M; Liberopoulos EN; Elisaf MS
    Obes Rev; 2008 Jul; 9(4):378-87. PubMed ID: 18034790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ileal transposition provides insight into the effectiveness of gastric bypass surgery.
    Strader AD
    Physiol Behav; 2006 Jun; 88(3):277-82. PubMed ID: 16782138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of immunosuppression on patients undergoing bariatric surgery.
    Gagné DJ; Papasavas PK; Dovec EA; Urbandt JE; Caushaj PF
    Surg Obes Relat Dis; 2009; 5(3):339-45. PubMed ID: 18951067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review: fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes.
    Byrne CD
    ACP J Club; 2005; 142(1):18. PubMed ID: 15656559
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study.
    Anagnostis P; Selalmatzidou D; Sapranidis M; Panagiotou A; Polyzos SA; Slavakis A; Kita M
    Indian J Endocrinol Metab; 2012 Jan; 16(1):146-7. PubMed ID: 22276270
    [No Abstract]   [Full Text] [Related]  

  • 40. Review: orlistat and sibutramine are modestly effective for weight loss at 1 year.
    Byrne CD; Wild S
    ACP J Club; 2005; 142(1):19. PubMed ID: 15656560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.